Literature DB >> 11259604

Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.

M Balzar1, I H Briaire-de Bruijn, H A Rees-Bakker, F A Prins, W Helfrich, L de Leij, G Riethmüller, S Alberti, S O Warnaar, G J Fleuren, S V Litvinov.   

Abstract

Ep-CAM is a new type of cell adhesion molecule (CAM) which does not structurally resemble the members of the four major families (cadherins, integrins, selectins, and CAMs of the immunoglobulin superfamily) and mediates Ca(2+)-independent, homophilic adhesions. The extracellular domain of Ep-CAM consists of a cysteine-rich region, containing two type II epidermal growth factor (EGF)-like repeats, followed by a cysteine-poor region. We generated mutated Ep-CAM forms with various deletions in the extracellular domain. These deletion mutants, together with monoclonal antibodies recognizing different epitopes in the extracellular domain, were used to investigate the role of the EGF-like repeats in the formation of intercellular contacts mediated by Ep-CAM molecules. We established that both EGF-like repeats are required for the formation of Ep-CAM-mediated homophilic adhesions, including the accumulation of Ep-CAM molecules at the cell-cell boundaries, and the anchorage of the Ep-CAM adhesion complex to F-actin via alpha-actinin. Deletion of either EGF-like repeat was sufficient to inhibit the adhesion properties of the molecule. The first EGF-like repeat of Ep-CAM is required for reciprocal interactions between Ep-CAM molecules on adjacent cells, as was demonstrated with blocking antibodies. The second EGF-like repeat was mainly required for lateral interactions between Ep-CAM molecules. Lateral interactions between Ep-CAM molecules result in the formation of tetramers, which might be the first and necessary step in the formation of Ep-CAM-mediated intercellular contacts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259604      PMCID: PMC86888          DOI: 10.1128/MCB.21.7.2570-2580.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Cell adhesion: integrating circuitry.

Authors:  A F Horwitz; T Hunter
Journal:  Trends Cell Biol       Date:  1996-12       Impact factor: 20.808

2.  Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes.

Authors:  W Helfrich; P W Koning; T H The; L De Leij
Journal:  Int J Cancer Suppl       Date:  1994

Review 3.  The structure of cell-adhesion molecules.

Authors:  M J Humphries; P Newham
Journal:  Trends Cell Biol       Date:  1998-02       Impact factor: 20.808

4.  The structural analysis of adhesions mediated by Ep-CAM.

Authors:  M Balzar; F A Prins; H A Bakker; G J Fleuren; S O Warnaar; S V Litvinov
Journal:  Exp Cell Res       Date:  1999-01-10       Impact factor: 3.905

Review 5.  Cell adhesion molecules and neuronal regeneration.

Authors:  F S Walsh; P Doherty
Journal:  Curr Opin Cell Biol       Date:  1996-10       Impact factor: 8.382

6.  The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease.

Authors:  M P Velders; C M van Rhijn; I M Cornelissen; G N van Muijen; I H Briaire; M Dohlsten; G J Fleuren; S O Warnaar; S V Litvinov
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1996-07

Review 7.  Morphogenetic roles of classic cadherins.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

Review 8.  The biology of the 17-1A antigen (Ep-CAM).

Authors:  M Balzar; M J Winter; C J de Boer; S V Litvinov
Journal:  J Mol Med (Berl)       Date:  1999-10       Impact factor: 4.599

Review 9.  Protein tyrosine phosphatases as adhesion receptors.

Authors:  S M Brady-Kalnay; N K Tonks
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

10.  Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas.

Authors:  M Fornaro; R Dell'Arciprete; M Stella; C Bucci; M Nutini; M G Capri; S Alberti
Journal:  Int J Cancer       Date:  1995-09-04       Impact factor: 7.396

View more
  54 in total

Review 1.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.

Authors:  Fabiana Pirani Carneiro; Maria Imaculada Muniz-Junqueira; Marcos De Vasconcelos Carneiro; Ísis De Araújo Oliveira; Aluízio Carlos Soares; Nathália De Vargas Haar; Gustavo Henrique Soares Takano; Leonora Maciel De Sousa Vianna; Guilherme De Carvalho Caldas; Danillo Leal Marinho Vieira; Lígia Lins Frutuoso; Larissa Matos Rodrigues Brito; Rafael Vieira Martins De Siqueira; Amanda Moreira Parente; Tercia Maria Mendes Lousa De Castro; Isabela Peres; Lianna Martha Soares Mendes; Tatiana Karla Dos Santos Borges; Vânia Moraes Ferreira; Andrea Barretto Motoyama
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

Review 3.  The multiple roles of epidermal growth factor repeat O-glycans in animal development.

Authors:  Amanda R Haltom; Hamed Jafar-Nejad
Journal:  Glycobiology       Date:  2015-07-14       Impact factor: 4.313

4.  Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization.

Authors:  Robert F Klees; Roman M Salasznyk; Donald F Ward; Donna E Crone; William A Williams; Mark P Harris; Adele Boskey; Vito Quaranta; George E Plopper
Journal:  Exp Cell Res       Date:  2008-01-22       Impact factor: 3.905

5.  EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.

Authors:  Ya-Ting Hsu; Pawel Osmulski; Yao Wang; Yi-Wen Huang; Lu Liu; Jianhua Ruan; Victor X Jin; Nameer B Kirma; Maria E Gaczynska; Tim Hui-Ming Huang
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

6.  Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.

Authors:  Daniel A Vallera; Bin Zhang; Michelle K Gleason; Seunguk Oh; Louis M Weiner; Dan S Kaufman; Valarie McCullar; Jeffrey S Miller; Michael R Verneris
Journal:  Cancer Biother Radiopharm       Date:  2013-04-23       Impact factor: 3.099

7.  Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.

Authors:  Dalibor Antolovic; Luis Galindo; Anina Carstens; Nuh Rahbari; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  BMC Biotechnol       Date:  2010-04-28       Impact factor: 2.563

8.  A novel family of cyst proteins with epidermal growth factor repeats in Giardia lamblia.

Authors:  Pei-Wei Chiu; Yu-Chang Huang; Yu-Jiao Pan; Chih-Hung Wang; Chin-Hung Sun
Journal:  PLoS Negl Trop Dis       Date:  2010-05-11

Review 9.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

10.  Abnormal placental development and early embryonic lethality in EpCAM-null mice.

Authors:  Keisuke Nagao; Jianjian Zhu; Mallorie B Heneghan; Jeffrey C Hanson; Maria I Morasso; Lino Tessarollo; Susan Mackem; Mark C Udey
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.